196 related articles for article (PubMed ID: 21335544)
21. Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy.
O'Malley FP; Chia S; Tu D; Shepherd LE; Levine MN; Bramwell VH; Andrulis IL; Pritchard KI
J Natl Cancer Inst; 2009 May; 101(9):644-50. PubMed ID: 19401546
[TBL] [Abstract][Full Text] [Related]
22. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma.
Fritz B; Schubert F; Wrobel G; Schwaenen C; Wessendorf S; Nessling M; Korz C; Rieker RJ; Montgomery K; Kucherlapati R; Mechtersheimer G; Eils R; Joos S; Lichter P
Cancer Res; 2002 Jun; 62(11):2993-8. PubMed ID: 12036902
[TBL] [Abstract][Full Text] [Related]
23. Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1.
Kanojia D; Kirtonia A; Srujana NSV; Jeevanandan SP; Shyamsunder P; Sampath SS; Dakle P; Mayakonda A; Kaur H; Yanyi J; Koeffler HP; Garg M
Pharmacol Res; 2022 Nov; 185():106462. PubMed ID: 36167276
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Bioinformatic Analysis Genes Associated to the Prognosis of Liposarcoma.
Liu J; Li R; Liao X; Jiang W
Med Sci Monit; 2018 Oct; 24():7329-7339. PubMed ID: 30317246
[TBL] [Abstract][Full Text] [Related]
25. Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas.
Taylor BS; DeCarolis PL; Angeles CV; Brenet F; Schultz N; Antonescu CR; Scandura JM; Sander C; Viale AJ; Socci ND; Singer S
Cancer Discov; 2011 Dec; 1(7):587-97. PubMed ID: 22328974
[TBL] [Abstract][Full Text] [Related]
26. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.
Barretina J; Taylor BS; Banerji S; Ramos AH; Lagos-Quintana M; Decarolis PL; Shah K; Socci ND; Weir BA; Ho A; Chiang DY; Reva B; Mermel CH; Getz G; Antipin Y; Beroukhim R; Major JE; Hatton C; Nicoletti R; Hanna M; Sharpe T; Fennell TJ; Cibulskis K; Onofrio RC; Saito T; Shukla N; Lau C; Nelander S; Silver SJ; Sougnez C; Viale A; Winckler W; Maki RG; Garraway LA; Lash A; Greulich H; Root DE; Sellers WR; Schwartz GK; Antonescu CR; Lander ES; Varmus HE; Ladanyi M; Sander C; Meyerson M; Singer S
Nat Genet; 2010 Aug; 42(8):715-21. PubMed ID: 20601955
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.
Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry J; Scolyer RA; Davies MJ; Heinzelmann M; Kalish LH; Bali A; Kench JG; Edwards LS; Vanden Bergh PM; Hacker NF; Sutherland RL; O'Brien PM
Clin Cancer Res; 2004 Jul; 10(13):4427-36. PubMed ID: 15240533
[TBL] [Abstract][Full Text] [Related]
28. Genomic landscape of liposarcoma.
Kanojia D; Nagata Y; Garg M; Lee DH; Sato A; Yoshida K; Sato Y; Sanada M; Mayakonda A; Bartenhagen C; Klein HU; Doan NB; Said JW; Mohith S; Gunasekar S; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Myklebost O; Yang H; Dugas M; Meza-Zepeda LA; Silberman AW; Forscher C; Tyner JW; Ogawa S; Koeffler HP
Oncotarget; 2015 Dec; 6(40):42429-44. PubMed ID: 26643872
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of topoisomerase 2A expression and gene change in operable invasive breast cancer.
Qiao JH; Jiao DC; Lu ZD; Yang S; Liu ZZ
Tumour Biol; 2015 Sep; 36(9):6833-8. PubMed ID: 25846735
[TBL] [Abstract][Full Text] [Related]
30. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
[TBL] [Abstract][Full Text] [Related]
31. Topoisomerase IIalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer.
Schindlbeck C; Mayr D; Olivier C; Rack B; Engelstaedter V; Jueckstock J; Jenderek C; Andergassen U; Jeschke U; Friese K
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1029-37. PubMed ID: 20052594
[TBL] [Abstract][Full Text] [Related]
32. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
[TBL] [Abstract][Full Text] [Related]
33. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
[TBL] [Abstract][Full Text] [Related]
35. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.
Pearlstone DB; Pisters PW; Bold RJ; Feig BW; Hunt KK; Yasko AW; Patel S; Pollack A; Benjamin RS; Pollock RE
Cancer; 1999 Jan; 85(1):85-92. PubMed ID: 9921978
[TBL] [Abstract][Full Text] [Related]
36. Functional genomics analysis reveals a MYC signature associated with a poor clinical prognosis in liposarcomas.
Tran D; Verma K; Ward K; Diaz D; Kataria E; Torabi A; Almeida A; Malfoy B; Stratford EW; Mitchell DC; Bryan BA
Am J Pathol; 2015 Mar; 185(3):717-28. PubMed ID: 25622542
[TBL] [Abstract][Full Text] [Related]
37. Prediction of epigenetically regulated genes in breast cancer cell lines.
Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcript.
De Cecco L; Gariboldi M; Reid JF; Lagonigro MS; Tamborini E; Albertini V; Staurengo S; Pilotti S; Pierotti MA
Histopathology; 2005 Mar; 46(3):334-41. PubMed ID: 15720420
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma.
Chen R; Khatri P; Mazur PK; Polin M; Zheng Y; Vaka D; Hoang CD; Shrager J; Xu Y; Vicent S; Butte AJ; Sweet-Cordero EA
Cancer Res; 2014 May; 74(10):2892-902. PubMed ID: 24654231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
